In a study of risk factors for reduced serum bicarbonate in patients with CKD [110], the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a higher risk for having lower serum bicarbonate levels. This evidence concerns the gene ACE and chronic kidney disease.